Biotechnology This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO – Regenxbio (NASDAQ:RGNX) Read more
Biotechnology Gene Therapy Player REGENXBIO’s RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst – Regenxbio (NASDAQ:RGNX) Read more
Biotechnology Why Is Adverum Biotechnologies Stock Trading Lower Today? – Adverum Biotechnologies (NASDAQ:ADVM) Read more